Clinical trialists can complete economic evaluations of new drug treatments and assess the impact of new treatments across different patient groups using simulation.
Simulation allows for unlimited scenarios to be tested in a risk free environment, supporting decision making and creating visibility among those involved.
Read how SIMUL8 was used to undertake the economic evaluation of the Adjuvant Breast Cancer (ABC) Trial. Read more...
Pharmaceutical and Life Sciences companies are turning to knowledge management solutions, such as SIMUL8 and Scenario Generator, to provide complete intelligence, deliver critical information and confirm the effectiveness of drug treatments.
Global Health Economics CEO, Ron Shannon, highlights "speed, ease of use and robust, credible results" as key factors in choosing SIMUL8 to perform economic analysis of specific treatments.
Read full article - Optimizing the value of data and simulation